# NCT04928807 (NCT04928807)

> Short-Course Radiotherapy Followed by Neoadjuvant Chemotherapy and Camrelizumab in Locally Advanced Rectal Cancer (UNION)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04928807
- Phase: PHASE3
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Conditions: Rectal Cancer
- Interventions: Short course radiotherapy sequential camrelizumab and chemotherapy
- Enrollment: 231
- Primary outcome: pathological complete response (pCR) rate

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=nct04928807